Bondensgaard; Kent
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bondensgaard; Kent.The latest application filed is for "methods of treating pruritic disease with il-31 monoclonal antibodies".
- Bondensgaard; Kent - Vaerlose DK
- Bondensgaard; Kent - V.ae butted.rlose DK
| Patent | Date |
|---|---|
| Methods Of Treating Pruritic Disease With Il-31 Monoclonal Antibodies App 20200262913 - Bondensgaard; Kent ; et al. | 2020-08-20 |
| Nucleic acid molecules encoding humanized IL-31 monoclonal antibodies Grant 10,640,559 - Bondensgaard , et al. | 2020-05-05 |
| Nucleic Acid Molecules Encoding Humanized Il-31 Monoclonal Antibodies App 20180305448 - Bondensgaard; Kent ; et al. | 2018-10-25 |
| Method of treating pruritus with IL-31 monoclonal antibody formulations Grant 9,982,044 - Bondensgaard , et al. May 29, 2 | 2018-05-29 |
| Method Of Treating Pruritus With Il-31 Monoclonal Antibody Formulations App 20170313768 - Bondensgaard; Kent ; et al. | 2017-11-02 |
| IL-31 monoclonal antibody formulations Grant 9,738,715 - Bondensgaard , et al. August 22, 2 | 2017-08-22 |
| Il-31 Monoclonal Antibody Formulations App 20160311898 - Bondensgaard; Kent ; et al. | 2016-10-27 |
| Method of treating pruritus with IL-31 monoclonal antibodies Grant 9,416,184 - Bondensgaard , et al. August 16, 2 | 2016-08-16 |
| Method Of Treating Pruritus With Il-31 Monoclonal Antibodies App 20150183868 - Bondensgaard; Kent ; et al. | 2015-07-02 |
| Polynucleotides encoding IL-31 monoclonal antibodies Grant 9,005,921 - Bondensgaard , et al. April 14, 2 | 2015-04-14 |
| Polynucleotides Encoding Il-31 Monoclonal Antibodies App 20140186891 - BONDENSGAARD; Kent ; et al. | 2014-07-03 |
| Nucleic acid molecules encoding humanized antibody molecules specific for IL-31 Grant 8,685,669 - Bondensgaard , et al. April 1, 2 | 2014-04-01 |
| Humanized Antibody Molecules Specific For Il-31 App 20130295611 - Bondensgaard; Kent ; et al. | 2013-11-07 |
| IL-21 variants Grant 8,475,784 - Hjorth , et al. July 2, 2 | 2013-07-02 |
| Humanized antibody molecules specific for IL-31 Grant 8,470,979 - Bondensgaard , et al. June 25, 2 | 2013-06-25 |
| Interleukin-21 variants with altered binding to the IL-21 receptor Grant 8,211,420 - Bondensgaard , et al. July 3, 2 | 2012-07-03 |
| Interleukin-21 Variants Having Antagonistic Binding To The Il-21 Receptor App 20120107267 - Kang; Lishan ; et al. | 2012-05-03 |
| Il-21 Variants App 20120082996 - Hjorth; Siv Annegrethe ; et al. | 2012-04-05 |
| IL-21 variants Grant 8,034,326 - Hjorth , et al. October 11, 2 | 2011-10-11 |
| Peptides with high affinity for the prolactin receptor App 20100249029 - Breinholt; Jens ; et al. | 2010-09-30 |
| Interleukin-21 Variants With Altered Binding To The Il-21 Receptor App 20100196309 - Bondensgaard; Kent ; et al. | 2010-08-05 |
| Humanized Antibody Molecules Specific For Il-31 App 20090208494 - Bondensgaard; Kent ; et al. | 2009-08-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 